These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30830838)

  • 1. A Theoretical Model for Predicting and Optimizing
    Ma W; Wang X; Liu W; Ma H; Su Y; Yang Y; Liu N; Wang Y; Yang G
    Radiat Res; 2019 May; 191(5):475-482. PubMed ID: 30830838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Preclinical Evaluation of 211At Labeled Anti-mesothelin Antibodies as Potential Targeted Alpha Therapy Drugs.
    Wang X; Ma W; Liu W; Ma H; Yang Y; Wang Y; Liu N; Yang G
    J Radiat Res; 2020 Sep; 61(5):684-690. PubMed ID: 32648573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
    Li Y; Tian Z; Rizvi SM; Bander NH; Allen BJ
    Prostate Cancer Prostatic Dis; 2002; 5(1):36-46. PubMed ID: 15195129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225.
    Castillo Seoane D; de Saint-Hubert M; Crabbe M; Struelens L; Koole M
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):265-277. PubMed ID: 32441067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Wüstemann T; Barelli P; Kim D; Williams C; Zheng X; Bi C; Hu B; Warren JD; Hage DS; DiMagno SG; Babich JW
    J Nucl Med; 2017 Sep; 58(9):1442-1449. PubMed ID: 28450562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B.
    Li HK; Hasegawa S; Nakajima NI; Morokoshi Y; Minegishi K; Nagatsu K
    Biochem Biophys Res Commun; 2018 Dec; 506(4):1078-1084. PubMed ID: 30409432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes.
    Palm S; Bäck T; Lindegren S; Hultborn R; Jacobsson L; Albertsson P
    J Nucl Med; 2018 Apr; 59(4):646-651. PubMed ID: 29175984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of activity by alpha-camera imaging and small-scale dosimetry within ovarian carcinoma micrometastases treated with targeted alpha therapy.
    Chouin N; Lindegren S; Jensen H; Albertsson P; Bäck T
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):487-95. PubMed ID: 23358400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted alpha-particle immunotherapy for acute myeloid leukemia.
    Jurcic JG; Rosenblat TL
    Am Soc Clin Oncol Educ Book; 2014; ():e126-31. PubMed ID: 24857092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.
    Dekempeneer Y; Keyaerts M; Krasniqi A; Puttemans J; Muyldermans S; Lahoutte T; D'huyvetter M; Devoogdt N
    Expert Opin Biol Ther; 2016 Aug; 16(8):1035-47. PubMed ID: 27145158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pre-clinical characterization of an alpha-emitting sigma-2 receptor targeted radiotherapeutic.
    Makvandi M; Lieberman BP; LeGeyt B; Hou C; Mankoff DA; Mach RH; Pryma DA
    Nucl Med Biol; 2016 Jan; 43(1):35-41. PubMed ID: 26702785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL13RA2 targeted alpha particle therapy against glioblastomas.
    Sattiraju A; Solingapuram Sai KK; Xuan A; Pandya DN; Almaguel FG; Wadas TJ; Herpai DM; Debinski W; Mintz A
    Oncotarget; 2017 Jun; 8(26):42997-43007. PubMed ID: 28562337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantage of antibody cocktails for targeted alpha therapy depends on specific activity.
    Pasternack JB; Domogauer JD; Khullar A; Akudugu JM; Howell RW
    J Nucl Med; 2014 Dec; 55(12):2012-9. PubMed ID: 25349219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
    Jiang L; Chen J; He Y; Zhang Y; Li G
    J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
    McDevitt MR; Barendswaard E; Ma D; Lai L; Curcio MJ; Sgouros G; Ballangrud AM; Yang WH; Finn RD; Pellegrini V; Geerlings MW; Lee M; Brechbiel MW; Bander NH; Cordon-Cardo C; Scheinberg DA
    Cancer Res; 2000 Nov; 60(21):6095-100. PubMed ID: 11085533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.
    Kiess AP; Minn I; Vaidyanathan G; Hobbs RF; Josefsson A; Shen C; Brummet M; Chen Y; Choi J; Koumarianou E; Baidoo K; Brechbiel MW; Mease RC; Sgouros G; Zalutsky MR; Pomper MG
    J Nucl Med; 2016 Oct; 57(10):1569-1575. PubMed ID: 27230930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
    Allen BJ
    Australas Phys Eng Sci Med; 2017 Jun; 40(2):369-376. PubMed ID: 28342027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities.
    Lan SF; Starly B
    Toxicol Appl Pharmacol; 2011 Oct; 256(1):62-72. PubMed ID: 21839104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted alpha therapy using Radium-223: From physics to biological effects.
    Marques IA; Neves AR; Abrantes AM; Pires AS; Tavares-da-Silva E; Figueiredo A; Botelho MF
    Cancer Treat Rev; 2018 Jul; 68():47-54. PubMed ID: 29859504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.